Left Ventricular Assist Systems (LVAS) are approved in the US as a Bridge to Transplantation
(BTT) or Destination Therapy (DT). However, patients (pts) with relative contraindications
(RCI) to cardiac transplant (tx), that nominally preclude listing but may resolve
during support, are ineligible under these currently approved indications.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of Heart and Lung TransplantationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.